{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:31:55Z","timestamp":1791318715444,"version":"4.3.1"},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1590\/s0100-879x2005000200006","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T16:52:49Z","timestamp":1113411169000},"page":"185-195","source":"Crossref","is-referenced-by-count":40,"title":["One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease"],"prefix":"10.1590","volume":"38","author":[{"given":"A.C.","family":"Barreto","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Franchi","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.R.P.","family":"Castro","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Lopes","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich S","year":"1992","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): Results of a randomized trial","volume":"112","author":"Rubin LJ","year":"1990","journal-title":"Annals of Internal Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-121-6-199409150-00003","article-title":"Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin","volume":"121","author":"Barst RJ","year":"1994","journal-title":"Annals of Internal Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst RJ","year":"1996","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig EB","year":"1999","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/thx.54.3.273","article-title":"Treatment of pulmonary hypertension secondary to connective tissue diseases","volume":"54","author":"Sanchez O","year":"1999","journal-title":"Thorax","ISSN":"https:\/\/id.crossref.org\/issn\/0040-6376","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized, controlled trial","volume":"132","author":"Badesch DB","year":"2000","journal-title":"Annals of Internal Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","article-title":"Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial","volume":"39","author":"Gali\u00e8 N","year":"2002","journal-title":"Journal of the American College of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau G","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski H","year":"2002","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid A","year":"1993","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref12","first-page":"48","article-title":"Relation of endothelin-1 to survival in patients with primary pulmonary hypertension: 273","volume":"26","author":"Gali\u00e8 N","year":"1996","journal-title":"European Journal of Clinical Investigation","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2972","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin LJ","year":"2002","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1378\/chest.124.1.247","article-title":"Effects of the dual endothelin receptor antagonist Bosentan in patients with pulmonary arterial hypertension: A 1-year follow-up study","volume":"124","author":"Sitbon O","year":"2003","journal-title":"Chest","ISSN":"https:\/\/id.crossref.org\/issn\/0012-3692","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1073\/pnas.91.16.7583","article-title":"Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase","volume":"91","author":"Archer SL","year":"1994","journal-title":"Proceedings of the National Academy of Sciences, USA"},{"key":"ref16","first-page":"L1126","article-title":"Atrial natriuretic peptide accounts for increased cGMP in hypoxia-induced hypertensive rat lungs","volume":"272","author":"Muramatsu M","year":"1997","journal-title":"American Journal of Physiology","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9513","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP phosphodiesterase-5: target of sildenafil","volume":"274","author":"Corbin JD","year":"1999","journal-title":"Journal of Biological Chemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1155\/2003\/612905","article-title":"Sildenafil treatment of primary pulmonary hypertension","volume":"10","author":"Laupland KB","year":"2003","journal-title":"Canadian Respiratory Journal","ISSN":"https:\/\/id.crossref.org\/issn\/1198-2241","issn-type":"print"},{"key":"ref19","first-page":"297","article-title":"Sildenafil in the management of primary pulmonary hypertension","volume":"54","author":"Singh B","year":"2002","journal-title":"Indian Heart Journal","ISSN":"https:\/\/id.crossref.org\/issn\/0019-4832","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1742-1241.2002.tb11281.x","article-title":"Sildenafil for primary pulmonary hypertension: short and long-term symptomatic benefit","volume":"56","author":"Jackson G","year":"2002","journal-title":"International Journal of Clinical Practice","ISSN":"https:\/\/id.crossref.org\/issn\/1368-5031","issn-type":"print"},{"key":"ref21","first-page":"676","article-title":"Sildenafil in primary pulmonary hypertension - is there a subset of patients who respond favourably?","volume":"18","author":"Sayin T","year":"2002","journal-title":"Canadian Journal of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0828-282X","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mcp.2002.123554","article-title":"Sildenafil for primary and secondary pulmonary hypertension","volume":"71","author":"Watanabe H","year":"2002","journal-title":"Clinical Pharmacology and Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9236","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/01.CIR.0000099502.17776.C2","article-title":"Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension","volume":"108","author":"Michelakis ED","year":"2003","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2003.10.056","article-title":"Clinical efficacy of sildenafil in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover study","volume":"43","author":"Sastry BKS","year":"2004","journal-title":"Journal of the American College of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"key":"ref25","first-page":"404","article-title":"Chronic oral sildenafil therapy in severe pulmonary artery hypertension","volume":"54","author":"Kothari SS","year":"2002","journal-title":"Indian Heart Journal","ISSN":"https:\/\/id.crossref.org\/issn\/0019-4832","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0735-1097(03)00555-2","article-title":"Oral sildenafil as a long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension","volume":"42","author":"Ghofrani HA","year":"2003","journal-title":"Journal of the American College of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","article-title":"Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension","volume":"136","author":"Ghofrani HA","year":"2002","journal-title":"Annals of Internal Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1161\/01.CIR.0000016641.12984.DC","article-title":"Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide","volume":"105","author":"Michelakis E","year":"2002","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.125.2.580","article-title":"Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension","volume":"125","author":"Leuchte HH","year":"2004","journal-title":"Chest","ISSN":"https:\/\/id.crossref.org\/issn\/0012-3692","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(02)11024-5","article-title":"Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomized controlled trial","volume":"360","author":"Ghofrani HA","year":"2002","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200210-1157BC","article-title":"Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension","volume":"167","author":"Ghofrani HA","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"key":"ref33","first-page":"377","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg GA","year":"1982","journal-title":"Medicine and Science in Sports and Exercise","ISSN":"https:\/\/id.crossref.org\/issn\/0195-9131","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.80.2.353","article-title":"Two-dimensional and Doppler echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension","volume":"80","author":"Eysmann SB","year":"1989","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival","volume":"40","author":"Sitbon O","year":"2002","journal-title":"Journal of the American College of Cardiology","ISSN":"https:\/\/id.crossref.org\/issn\/0735-1097","issn-type":"print"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1378\/chest.123.4.1293","article-title":"Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension","volume":"123","author":"Stiebellehner L","year":"2003","journal-title":"Chest","ISSN":"https:\/\/id.crossref.org\/issn\/0012-3692","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/hc3601.096826","article-title":"Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension","volume":"104","author":"Wilkens H","year":"2001","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1164\/rccm.200208-861OC","article-title":"Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II","volume":"167","author":"Runo JR","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1378\/chest.122.3.1096","article-title":"Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease","volume":"122","author":"Okumura O","year":"2002","journal-title":"Chest","ISSN":"https:\/\/id.crossref.org\/issn\/0012-3692","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1378\/chest.113.1.237","article-title":"Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease","volume":"113","author":"Palmer S","year":"1998","journal-title":"Chest","ISSN":"https:\/\/id.crossref.org\/issn\/0012-3692","issn-type":"print"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v38n2\/5525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T20:20:50Z","timestamp":1706127650000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2005000200006&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0100-879X2005000200006"],"URL":"https:\/\/doi.org\/10.1590\/s0100-879x2005000200006","relation":{},"ISSN":["0100-879X"],"issn-type":[{"value":"0100-879X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}